Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, ...

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

AbbVie is seeking accelerated approval for its cancer drug Teliso-V following ... with non-small cell lung cancer have unmet medical needs and oncologists are looking for new treatment options ...

Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4, 2024 — The University of Cincinnati's Debanjan Bhattacharya is first author of new research ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

A New Ventilator-on-a-Chip Model to Study ... Diabetes Drug Reduces Drug Resistance in Lung Cancer, Improving Chemotherapy Effectiveness July 17, 2024 — A medication used to treat diabetic ...

The Pharmaceuticals and Medical Devices Agency (PMDA) has accelerated approvals, with eight new lung cancer drugs authorized in the past two years, enhancing the treatment landscape. Furthermore ...

As we head towards Lung Cancer Awareness Month in November disease healthcare organization LUNGevity Foundation is launching a new awareness campaign with backing from major lung cancer drug players.

Sydney woman Jemma Juckes is eagerly awaiting this week’s decision on whether a groundbreaking new cancer drug will be added to the pharmaceutical benefits scheme. Her life depends on it.